Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients

Lung

Volumn 190, Issue 1, 2012, Pages 91-98

  Li, Weiying ^a   Yue, Wentao ^a   Zhang, Lina ^a   Zhao, Xiaoting ^a   Ma, Li ^a   Yang, Xuehui ^a   Zhang, Chunyan ^a   Wang, Yue ^a   Gu, Meng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Genetic susceptibility; Non small cell lung cancer; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP2E1; DRUG RESISTANCE, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATINUM COMPOUNDS; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; SMOKING; YOUNG ADULT;

EID: 84857652625     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-011-9338-8     Document Type: Article

References (34)

1. Z Mo Y Gao Y Cao F Gao L Jian 2009 An updating meta-analysis of the GSTM1, GSTT1 and GSTP1 polymorphisms and prostate cancer: a HuGE review Prostate 69 662 688 19143011 10.1002/pros.20907 1:CAS:528:DC%2BD1MXlslChsrw%3D
2. KM McCarty RM Santella SE Steck RJ Cleveland J Ahn CB Ambrosone, et al. 2009 PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk Environ Health Perspect 117 552 558 19440493 1:CAS:528:DC%2BD1MXksFygurg%3D
3. O Mir J Alexandre A Tran JP Durand G Pons JM Treluyer 2009 Relationship between GSTP1 IIe (105) Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity Ann Oncol 20 736 740 19223573 10.1093/annonc/mdn698 1:STN:280: DC%2BD1M3jt1Ojug%3D%3D
4. L Sreeja V Syamala S Hariharan VS Syamala PB Raveendran CD Sivanandan, et al. 2008 Glutathinone S-transferases M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients J Exp Ther Oncol 7 73 85 18472644 1:CAS:528:DC%2BD1cXlsV2lsL0%3D (Pubitemid 351521217)
5. JR Idle 1991 Is environmental carcinogenesis modulated by host polymorphism? Mutat Res 247 259 266 2011143 10.1016/0027-5107(91)90021-F 1:CAS:528:DyaK3MXit1artb0%3D
6. JW Kim CG Lee YG Park KS Kim IK Kim YW Sohn 2000 Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relationship to the incidence rate of cervical carcinoma Cancer 88 2082 2091 10813720 10.1002/(SICI)1097-0142(20000501)88:9<2082::AID-CNCR14>3.0.CO;2-D 1:CAS:528:DC%2BD3cXjtF2mu74%3D (Pubitemid 30233210)
7. E Reszka W Wasowicz J Gromadzinska 2006 Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility Br J Nutr 96 609 619 17010218 1:CAS:528:DC%2BD28XhtFKktr%2FL (Pubitemid 46470184)
8. H Singh R Sachan S Devi SN Pandey B Mittal 2008 Association of GSTM1, GSTT1, GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population Am J Obstet Gynecol 198 303e1 303e6 10.1016/j.ajog.2007.09. 046
9. X Shi S Zhou Z Wang Z Zhou 2008 CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese population: a meta-analysis Lung Cancer 59 155 163 17900751 10.1016/j.lungcan.2007.08.004 (Pubitemid 351173406)
10. T Joseph P Chacko R Wesley PG Jayaprakash FV James MR Pillai 2006 Germline genetic polymorphisms of CYP1A1, GSTM1 GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection Gynecol Oncol 101 411 417 16360200 10.1016/j.ygyno.2005.10.033 1:CAS:528:DC%2BD28XkvVClsbc%3D (Pubitemid 43729981)
11. A Khedhaier S Remadi M Corbex SB Ahmed, et al. 2003 Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma Br J Cancer 89 1502 1507 14562023 10.1038/sj.bjc.6601292 1:CAS:528:DC%2BD3sXotFeksLc%3D (Pubitemid 37386606)
12. CC Mellwain DM Townsend KD Tew 2006 Glutathione S-transferase polymorphisms: cancer incidence and therapy Oncogene 25 1639 1648 10.1038/sj.onc.1209373
13. A DeMichele P Gimotty J Botbyl, et al. 2007 In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort" J Clin Oncol 25 35 5675 5677 18065748 10.1200/JCO.2006.10.1485
14. WP Petros PJ Hopkins S Spruill, et al. 2005 Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer J Clin Oncol 23 25 6117 6125 16087946 10.1200/JCO.2005.06.075 1:CAS:528:DC%2BD2MXhtVKgtb3F
15. CB Ambrosone C Sweeney BF Coles, et al. 2001 Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer Cancer Res 61 19 7130 7135 11585745 1:CAS:528:DC%2BD3MXnsVehsb4%3D (Pubitemid 32946505)
16. B Amirimani B Ning AC Deitz BL Weber FF Kadlubar TR Rebbeck 2003 Increased transcriptional activity of the CYP3A4*1B promoter variant Environ Mol Mutagen 42 299 305 14673875 10.1002/em.10199 1:CAS:528: DC%2BD2cXlsFSjtA%3D%3D (Pubitemid 38054375)
17. M Eichelbaum M Ingelman-Sunberg WE Evans 2006 Pharmacogenomics and individualized drug therapy Annu Rev Med 57 119 137 16409140 10.1146/annurev.med.56.082103.104724 1:CAS:528:DC%2BD28Xis1Cks70%3D (Pubitemid 43261982)
18. A Beeghly D Katsaros H Chen, et al. 2006 Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival Gynecol Oncol 100 2 330 337 16199080 10.1016/j.ygyno.2005.08.035 1:CAS:528:DC%2BD28XjsFKqsw%3D%3D (Pubitemid 43075265)
19. A Tran V Jullien J Alexandre, et al. 2006 Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms Clin Pharmacol Ther 76 6 570 580 10.1016/j.clpt.2006.02.003 (Pubitemid 43833447)
20. E Barragan M Collado J Cervera, et al. 2007 The GST deletions and NQO1*2 polymorphisms confers interindividual variability of response to treatment in patients with acute myeloid leukemia Leuk Res 31 7 947 953 17118447 10.1016/j.leukres.2006.10.002 1:CAS:528:DC%2BD2sXmtlamsLs%3D (Pubitemid 46856725)
21. A Demichele R Aplenc J Botbyl, et al. 2005 Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort J Clin Oncol 23 24 5552 5553 16110016 10.1200/JCO.2005.06.208 1:CAS:528:DC%2BD2MXhtVersr%2FP
22. Y Zhang L Yang R Li, et al. 2006 The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia Zhonghua Nei Ke Za Zhi 45 3 213 216 16624155 1:CAS:528:DC%2BD2sXnvFWjsLw%3D
23. Tsvirenko SV, Tsaur GA (2006) Genetic polymorphism of glutathione-S-transferase M1 and T1 in children with acute lymphoblastic leukemia. Klin Lab Diagn (2):23-24, 33-34
24. R Medeiros D Pereira N Afonso, et al. 2003 Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome Int J Clin Oncol 8 3 156 161 12851839 10.1007/s10147-003-0318-8 1:CAS:528:DC%2BD3sXmt1WgsbY%3D (Pubitemid 36897285)
25. LN Sarab C Bruno C Pascal, et al. 1999 Glutathione S-transferase N1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer Breast Cancer Res 1 1 81 87 10.1186/bcr17 (Pubitemid 32223550)
26. MF Okcu M Selvan LE Wang, et al. 2004 Glutathione S-transferase polymorphisms and survival in primary malignant glioma Clin Cancer Res 10 8 2618 2625 15102663 10.1158/1078-0432.CCR-03-0053 1:CAS:528:DC%2BD2cXjt1Clt7w%3D (Pubitemid 38509134)
27. K Maja L Domian M Geraldine, et al. 2002 Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukaemia Clin Cancer Res 8 3 802 810
28. R Guo L Chen L Li, et al. 2011 Association of GSTM1 null polymorphism with isosorbide-5-mononitrate cardiovascular response and involvement of CGRP in healthy Chinese male volunteers Pharmacogenet Genomics 21 3 142 151 21278620 10.1097/FPC.0b013e328343ea0a 1:CAS:528:DC%2BC3MXhsFWhuro%3D
29. VA Ovsepian V EIu ES Sherstneva 2010 Cytochrome P4501A1, glutathione S-transferase M1 and T1 gene polymorphisms in chronic myeloid leukemia Genetika 46 10 1360 1362 21254556 1:STN:280:DC%2BC3M7jsFyqsA%3D%3D
30. AM Horgan B Yang AK Azad, et al. 2011 Pharmacogenetic and germline prognostic markers of lung cancer J Thorac Oncol 6 2 296 304 21206385 10.1097/JTO.0b013e3181ffe909
31. AL Oliveira FF Rodrigues RE Santos, et al. 2010 GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer Genet Mol Res 9 2 1045 1053 20568049 10.4238/vol9-2gmr726 1:CAS:528: DC%2BC3cXnvFSmtbw%3D
32. S Funke M Timofeeva A Risch, et al. 2010 Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy Pharmacogenomics 11 1 33 41 20017670 10.2217/pgs.09.132 1:CAS:528: DC%2BD1MXhsFOms7rJ
33. SD Baker J Verweij GA Cusatis, et al. 2009 Pharmacogenetic pathway analysis of docetaxel elimination Clin Pharmacol Ther 85 2 155 163 18509327 10.1038/clpt.2008.95 1:CAS:528:DC%2BD1MXmt1Cquw%3D%3D
34. VR Arruda CS Lima CR Grignoli, et al. 2001 Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects Eur J Haematol 66 6 383 388 11488937 10.1034/j.1600-0609.2001.066006383.x 1:CAS:528:DC%2BD3MXmtVKjs7g%3D (Pubitemid 32675096)